(VIANEWS) – ZoomInfo (ZI), NAPCO Security Technologies (NSSC), Vertex Pharmaceuticals (VRTX) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. ZoomInfo (ZI)

39.8% sales growth and 4.28% return on equity

ZoomInfo Technologies Inc. operates cloud-based go-to-market intelligence platform for sales and marketing teams in the United States and internationally.

ZoomInfo’s sales growth this year is expected to be 48.2% and 31.2% for next year.

Year-on-year quarterly revenue growth grew by 56.9%, now sitting on 590.4M for the twelve trailing months.

Volume

Today’s last reported volume for ZoomInfo is 23402300 which is 478.09% above its average volume of 4048210.

ZoomInfo’s sales growth for the next quarter is 39.8%. The company’s growth estimates for the ongoing quarter and the next is 9.1% and 8.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.28%.

Volatility

ZoomInfo’s last day, last week, and last month’s current intraday variation average was 4.49%, 7.06%, and 4.95%, respectively.

ZoomInfo’s highest amplitude of average volatility was 4.44% (day), 9.29% (last week), and 7.53% (last month), respectively.

ZoomInfo’s Stock Yearly Top and Bottom Value

ZoomInfo’s stock is valued at $0.00 at 19:22 EST, below its 52-week low of $37.86.

ZoomInfo’s Moving Average

ZoomInfo’s value is below its 50-day moving average of $67.86 and below its 200-day moving average of $56.40.

Previous days news about ZoomInfo(ZI)

  • According to Bloomberg Quint on Monday, 6 December, "The investment firm backed ZoomInfo Technologies Inc. in 2018, then helped it carry out a keyacquisition, court new customers and expand internationally, leading to aninitial public offering. "

2. NAPCO Security Technologies (NSSC)

22.3% sales growth and 9.5% return on equity

Napco Security Technologies, Inc. develops, manufactures, and sells security products in the United States and internationally.

NAPCO Security Technologies’s sales growth this year is expected to be 7% and 17.6% for next year.

Year-on-year quarterly revenue growth grew by 7.6%, now sitting on 101.61M for the twelve trailing months.

Volume

Today’s last reported volume for NAPCO Security Technologies is 84644 which is 31.58% above its average volume of 64326.

NAPCO Security Technologies’s sales growth for the next quarter is 22.3%. The company’s growth estimates for the present quarter and the next is a negative 0% and 100%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.5%.

Volatility

NAPCO Security Technologies’s last day, last week, and last month’s current intraday variation average was 0.80%, 0.70%, and 1.85%, respectively.

NAPCO Security Technologies’s highest amplitude of average volatility was 1.88% (day), 2.70% (last week), and 4.06% (last month), respectively.

NAPCO Security Technologies’s Stock Yearly Top and Bottom Value

NAPCO Security Technologies’s stock is valued at $46.11 at 19:22 EST, way below its 52-week high of $52.00 and way higher than its 52-week low of $25.27.

NAPCO Security Technologies’s Moving Average

NAPCO Security Technologies’s value is above its 50-day moving average of $45.98 and way higher than its 200-day moving average of $37.89.

3. Vertex Pharmaceuticals (VRTX)

17.4% sales growth and 24.64% return on equity

Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis.

Vertex Pharmaceuticals’s sales growth this year is anticipated to be 17.5% and 10.5% for next year.

Year-on-year quarterly revenue growth grew by 29%, now sitting on 7.13B for the twelve trailing months.

Volume

Today’s last reported volume for Vertex Pharmaceuticals is 1869310 which is 4.76% above its average volume of 1784300.

Vertex Pharmaceuticals’s sales growth is a negative 0% for the ongoing quarter and 17.4% for the next. The company’s growth estimates for the current quarter and the next is 15.9% and 24.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.64%.

Volatility

Vertex Pharmaceuticals’s last day, last week, and last month’s current intraday variation average was 0.08%, 2.19%, and 1.43%, respectively.

Vertex Pharmaceuticals’s highest amplitude of average volatility was 1.11% (day), 2.91% (last week), and 2.66% (last month), respectively.

Vertex Pharmaceuticals’s Stock Yearly Top and Bottom Value

Vertex Pharmaceuticals’s stock is valued at $205.22 at 19:22 EST, way under its 52-week high of $242.99 and way higher than its 52-week low of $176.36.

Vertex Pharmaceuticals’s Moving Average

Vertex Pharmaceuticals’s worth is way above its 50-day moving average of $184.35 and higher than its 200-day moving average of $200.51.

4. Randolph Bancorp (RNDB)

15.6% sales growth and 14.41% return on equity

Randolph Bancorp, Inc. operates as the bank holding company for Envision Bank that provides financial services to individuals, families, and small to mid-size businesses in Massachusetts, Rhode Island, and southern New Hampshire.

Randolph Bancorp’s sales growth this year is expected to be 17.7% and 8.5% for next year.

Year-on-year quarterly revenue growth declined by 40.8%, now sitting on 64.4M for the twelve trailing months.

Volume

Today’s last reported volume for Randolph Bancorp is 1676 which is 81.06% below its average volume of 8852.

Randolph Bancorp’s sales growth for the next quarter is 15.6%. The company’s growth estimates for the present quarter and the next is a negative 45.5% and negative -40.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.41%.

Volatility

Randolph Bancorp’s last day, last week, and last month’s current intraday variation average was 4.18%, 2.08%, and 1.81%, respectively.

Randolph Bancorp’s highest amplitude of average volatility was 3.21% (day), 4.38% (last week), and 4.70% (last month), respectively.

Randolph Bancorp’s Stock Yearly Top and Bottom Value

Randolph Bancorp’s stock is valued at $24.36 at 19:22 EST, way under its 52-week high of $27.40 and way above its 52-week low of $16.99.

Randolph Bancorp’s Moving Average

Randolph Bancorp’s value is higher than its 50-day moving average of $23.23 and way higher than its 200-day moving average of $21.31.

5. International Paper Company (IP)

13.2% sales growth and 21.53% return on equity

International Paper Company operates as a paper and packaging company primarily in United States, the Middle East, Europe, Africa, Pacific Rim, Asia, and the Americas.

International Paper Company’s sales growth this year is anticipated to be 10% and 2.9% for next year.

Year-on-year quarterly revenue growth grew by 11.5%, now sitting on 21.93B for the twelve trailing months.

Volume

Today’s last reported volume for International Paper Company is 5636610 which is 108.54% above its average volume of 2702840.

International Paper Company’s sales growth for the next quarter is 13.2%. The company’s growth estimates for the current quarter and the next is 112.7% and 102.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.53%.

Volatility

International Paper Company’s last day, last week, and last month’s current intraday variation average was 1.29%, 1.34%, and 1.28%, respectively.

International Paper Company’s highest amplitude of average volatility was 1.34% (day), 2.12% (last week), and 2.25% (last month), respectively.

International Paper Company’s Stock Yearly Top and Bottom Value

International Paper Company’s stock is valued at $45.52 at 19:22 EST, way under its 52-week high of $61.81 and above its 52-week low of $44.02.

International Paper Company’s Moving Average

International Paper Company’s value is way below its 50-day moving average of $50.97 and way under its 200-day moving average of $54.22.

6. Ingredion Incorporated (INGR)

9.6% sales growth and 5.76% return on equity

Ingredion Incorporated, together with its subsidiaries, produces and sells starches and sweeteners for various industries.

Ingredion Incorporated’s sales growth this year is anticipated to be 14.4% and 6.8% for next year.

Year-on-year quarterly revenue growth grew by 17.4%, now sitting on 6.73B for the twelve trailing months.

Volume

Today’s last reported volume for Ingredion Incorporated is 399964 which is 6.04% above its average volume of 377169.

Ingredion Incorporated’s sales growth for the next quarter is 9.6%. The company’s growth estimates for the current quarter and the next is a negative 23.4% and negative -4.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.76%.

Volatility

Ingredion Incorporated’s last day, last week, and last month’s current intraday variation average was 0.96%, 0.85%, and 1.10%, respectively.

Ingredion Incorporated’s highest amplitude of average volatility was 2.17% (day), 1.64% (last week), and 1.85% (last month), respectively.

Ingredion Incorporated’s Stock Yearly Top and Bottom Value

Ingredion Incorporated’s stock is valued at $1.15 at 19:22 EST, way under its 52-week low of $73.82.

Ingredion Incorporated’s Moving Average

Ingredion Incorporated’s value is way below its 50-day moving average of $94.96 and way below its 200-day moving average of $91.80.

7. Chubb Corporation (CB)

8.4% sales growth and 14.24% return on equity

Chubb Limited, through its subsidiaries, provides insurance and reinsurance products worldwide.

Chubb Corporation’s sales growth this year is anticipated to be 10.6% and 6.3% for next year.

Year-on-year quarterly revenue growth grew by 7.2%, now sitting on 39.04B for the twelve trailing months.

Volume

Today’s last reported volume for Chubb Corporation is 1351180 which is 21.67% below its average volume of 1725080.

Chubb Corporation’s sales growth for the next quarter is 8.4%. The company’s growth estimates for the present quarter and the next is 48.5% and 5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.24%.

Volatility

Chubb Corporation’s last day, last week, and last month’s current intraday variation average was 0.27%, 2.14%, and 1.23%, respectively.

Chubb Corporation’s highest amplitude of average volatility was 1.06% (day), 2.82% (last week), and 2.07% (last month), respectively.

Chubb Corporation’s Stock Yearly Top and Bottom Value

Chubb Corporation’s stock is valued at $188.04 at 19:22 EST, below its 52-week high of $197.92 and way higher than its 52-week low of $144.00.

Chubb Corporation’s Moving Average

Chubb Corporation’s worth is higher than its 50-day moving average of $183.95 and higher than its 200-day moving average of $174.65.

8. Proto Labs (PRLB)

8.4% sales growth and 4.28% return on equity

Proto Labs, Inc., together with its subsidiaries, operates as an e-commerce driven digital manufacturer of custom prototypes and on-demand production parts in the worldwide.

Proto Labs’s sales growth this year is expected to be 10.9% and 8.1% for next year.

Year-on-year quarterly revenue growth grew by 16.6%, now sitting on 469.72M for the twelve trailing months.

Volume

Today’s last reported volume for Proto Labs is 1121710 which is 132.08% above its average volume of 483322.

Proto Labs’s sales growth for the next quarter is 8.4%. The company’s growth estimates for the current quarter and the next is a negative 46% and negative -5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.28%.

Volatility

Proto Labs’s last day, last week, and last month’s current intraday variation average was 1.33%, 3.32%, and 3.04%, respectively.

Proto Labs’s highest amplitude of average volatility was 6.17% (day), 5.59% (last week), and 4.81% (last month), respectively.

Proto Labs’s Stock Yearly Top and Bottom Value

Proto Labs’s stock is valued at $50.12 at 19:22 EST, way below its 52-week high of $286.57 and higher than its 52-week low of $48.33.

Proto Labs’s Moving Average

Proto Labs’s worth is way under its 50-day moving average of $64.58 and way below its 200-day moving average of $91.14.

Previous days news about Proto Labs(PRLB)

  • According to CNBC on Friday, 3 December, "Berkeley Lights, Proto Labs and Skillz are all more than 80% below their 52-week highs."

LEAVE A REPLY

Please enter your comment!
Please enter your name here